Thursday, December 7, 2017

08/12/2017: PHARMAQ’s opens new production facility in Kløfta, Norway

On the 4th December PHARMAQ announced the opening of a new facility in Kløfta (Norway) for the production of viral antigens for use in fish vaccines
 

With the establishment of this state of the art facility, PHARMAQ has now the capacity to produce virus antigen for several hundred million vaccine doses annually and will ensure PHARMAQ’s delivery capacity to the international aquaculture industry for the future.

The plant received authorisation from the Norwegian Medicines Agency on November 1, 2017 and is counting up to twenty five employees.

“Today, we are extremely proud to open this new facility for virus antigen production in Norway” said Morten Nordstad, President PHARMAQ.

“Not only this facility will help secure fish vaccines production for the many years to come, but it also represents a real technological step forward in vaccine production for fish. This new site in Kløfta will ensure close cooperation with our R&D organisation in Oslo and our production facilities for bacterial antigens and finished vaccines in Overhalla.”

Visit the PHARMAQ website, HERE.



The Aquaculturists
This blog is maintained by The Aquaculturists staff and is supported by the
magazine International Aquafeed which is published by
Perendale Publishers Ltd

For additional daily news from aquaculture around the world: aquaculture-news

No comments:

Post a Comment




See our data and privacy policy Click here